Apollo Endosurgery (NASDAQ:APEN) Insider Buying and Selling Activity
Insider Ownership Percentage: 52.80%
Apollo Endosurgery (NASDAQ APEN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/27/2018 | Stonepine Capital, L.P. | Major Shareholder | Sell | 250,000 | $3.00 | $750,000.00 | 2,185,426 |  |
| 12/26/2018 | Stonepine Capital, L.P. | Major Shareholder | Sell | 500,000 | $3.00 | $1,500,000.00 | 2,435,426 | |
| 11/21/2018 | Stonepine Capital, L.P. | Major Shareholder | Buy | 57,430 | $3.41 | $195,836.30 | 2,932,196 | |
| 11/19/2018 | Stonepine Capital, L.P. | Major Shareholder | Buy | 54,200 | $3.40 | $184,280.00 | 2,932,196 | |
| 11/2/2018 | Stonepine Capital, L.P. | Major Shareholder | Buy | 300,000 | $5.00 | $1,500,000.00 | 2,877,996 | |
| 6/20/2018 | Matthew S Crawford | Director | Buy | 363,500 | $5.50 | $1,999,250.00 | | |
| 6/20/2018 | Stefanie L. Cavanaugh | CFO | Buy | 4,545 | $5.50 | $24,997.50 | | |
| 6/20/2018 | Todd Newton | CEO | Buy | 72,727 | $5.50 | $399,998.50 | 268,606 | |
| 3/9/2018 | Matthew S Crawford | Director | Buy | 4,038 | $6.20 | $25,035.60 | 53,715 | |
| 1/3/2018 | Stonepine Capital, L.P. | Major Shareholder | Buy | 22,845 | $5.71 | $130,444.95 | 2,560,314 | |
| 12/29/2017 | Stonepine Capital, L.P. | Major Shareholder | Buy | 5,163 | $5.56 | $28,706.28 | 2,560,314 | |
| 12/26/2017 | Stonepine Capital, L.P. | Major Shareholder | Buy | 5,287 | $5.00 | $26,435.00 | 2,555,151 | |
| 12/22/2017 | Stonepine Capital, L.P. | Major Shareholder | Buy | 185,157 | $4.85 | $898,011.45 | 2,410,141 | |
| 12/20/2017 | Stonepine Capital, L.P. | Major Shareholder | Buy | 45,434 | $4.50 | $204,453.00 | 2,410,141 | |
| 11/7/2017 | Bret Schwartzhoff | VP | Buy | 9,500 | $4.24 | $40,280.00 | 15,631 | |
| 7/26/2017 | Holdings A/S Novo | Major Shareholder | Sell | 50,130 | $6.90 | $345,897.00 | 1,334,772 | |
| 7/25/2017 | Richard J Meelia | Director | Buy | 45,454 | $5.50 | $249,997.00 | 5,098 | |
| 7/25/2017 | Sciences L P Ptv II | Major Shareholder | Buy | 1,090,909 | $5.50 | $5,999,999.50 | | |
| 7/25/2017 | Stefanie L Cavanaugh | CFO | Buy | 4,545 | $5.50 | $24,997.50 | 9,166 | |
| 7/25/2017 | Todd Newton | CEO | Buy | 136,363 | $5.50 | $749,996.50 | 167,129 | |
| 5/18/2017 | Todd Newton | CEO | Buy | 2,121 | $6.22 | $13,192.62 | 29,544 | |
| 5/17/2017 | William D Jr. Mcclellan | Director | Buy | 2,000 | $6.33 | $12,660.00 | | |
| 5/11/2017 | A/S Novo | Major Shareholder | Sell | 105,000 | $5.63 | $591,150.00 | 1,455,472 | |
| 12/12/2014 | Daniel H Petree | Director | Buy | 10,000 | $2.79 | $27,900.00 | | |
| 8/20/2014 | Gary J G Atkinson | CFO | Buy | 5,000 | $3.10 | $15,500.00 | | |
| 8/19/2014 | Scott R Pancoast | CEO | Buy | 10,000 | $3.00 | $30,000.00 | | |
| 8/18/2014 | Scott R Pancoast | CEO | Buy | 10,000 | $3.22 | $32,200.00 | | |
| 12/19/2012 | Charles Mathews | Director | Buy | 5,000 | $4.98 | $24,900.00 | | |
| 12/18/2012 | Scott R Pancoast | CEO | Buy | 5,000 | $4.95 | $24,750.00 | | |
(Data available from 1/1/2013 forward)
